ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT APRIL 2025

News provided by

05 May, 2025, 08:14 GMT

GOTHENBURG, Sweden, May 5, 2025 /PRNewswire/ -- Zinzino group revenue increased with a total of 54 %, compared with the previous year.

The revenue in April for Zinzino's sales markets increased by 58 % and amounted to SEK 249.5 (158.0) million. Faun Pharma's external sales decreased and amounted to SEK 6.2 (8.2) million. Overall, the Group increased revenues by 54 % to SEK 255.7 (166.2) million compared with the previous year.

Accumulated revenue for January – April 2025 increased by 58 % to SEK 979.4 (620.7) million.

Revenues were distributed as follows:

Regions,MSEK	25-Apr	24-Apr	Change	YTD 2025	YTD 2024	Change
The Nordics	23.5	25.0	-6 %	100.7	93.0	8 %
Central Europe	65.6	45.5	44 %	262.0	165.0	59 %
East Europe	27.2	31.1	-13 %	124.4	124.9	0 %
South & West Europe	45.0	26.4	70 %	169.9	97.1	75 %
The Baltics	8.7	8.2	6 %	37.4	32.0	17 %
North America	51.5	15.3	237 %	164.0	50.7	223 %
Asia-Pacific	26.3	5.4	387 %	92.1	17.8	417 %
Africa	1.7	1.1	55 %	6.7	4.4	52 %
Zinzino	249.5	158.0	58 %	957.2	584.9	64 %
Faun Pharma	6.2	8.2	-24 %	22.2	35.8	-38 %
Zinzino Group	255.7	166.2	54 %	979.4	620.7	58 %

Countries in regions:

The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
Central Europe: Austria, Germany, Switzerland
East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
The Baltics: Estonia, Latvia, Lithuania
North America: Canada, USA, Mexico
Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
Africa: South Africa